Proposal for Ex Vivo Chemoadjuvant Testing

For cancers that can be biopsied, it is now feasible to assess their sensitivities to chemotherapy drugs in the laboratory, before chemotherapy is done. This can often help oncologists to choose agents capable of effectively controlling the cancer, while avoiding the needless toxicity associated with use of ineffective drugs. This article suggests that, in an analogous manner, lab testing could be used to determine which adjuvant agents could best potentiate response to chosen chemotherapies.

Click to download